News

PipelineReview.com13h
Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases
SOUTH SAN FFRANCISCO, CA, USA and BAGSVAERD, Denmark I May 14, 2025 I Septerna, Inc. (Nasdaq: SEPN) and Novo Nordisk today announced an exclusive global ...
PipelineReview.com13h
Nuvig Therapeutics Announces First Patient Dosed in Phase 2 CIDP Trial of NVG-2089 and Presentation of Phase 1 Data
MENLO PARK, CA, USA I May 14, 2025 I Nuvig Therapeutics, Inc. (“Nuvig”), a privately held biotechnology company developing novel immunomodulatory therapeutics ...
PipelineReview.com13h
Rznomics Enters Global Licensing Agreement with Eli Lilly for RNA-editing Therapeutics
SEONGNAM, South Korea I May 15, 2025 I Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, announced today ...
PipelineReview.com13h
FDA Accepts Biologics License Application for Mucopolysaccharidosis II Treatment
PARAMUS, NJ, USA I May 14, 2025 I NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku) announced today that the U.S. Food ...
PipelineReview.com13h
aTyr Pharma Advances ATYR0101 to IND Candidate Stage for Pulmonary Fibrosis
Title: ATYR0101: A New Approach to Fibrosis Presenter: Ryan Adams, Ph.D., Senior Director, In Vitro Biology Session: Showcase Three: ILD/Fibrosis Date and Time: Saturday, May 17, 2025 at 11:30 AM PT ...